The SPDR S&P Telecom ETF (XTL) provides diversified exposure to U.S. telecom and communications equipment sectors, benefiting from AI-driven network demand and industry consolidation. It has delivered impressive returns of 50% annually and 200% over three years. Key growth drivers include AI data center expansion, fiber and 5G investments, and satellite-terrestrial integration. However, with a valuation of 16.7x P/E and recent price appreciation, further short-term upside is limited. The ETF is rated HOLD due to strong structural growth largely priced in and ongoing risks from economic cycles, interest rates, and competition.
The SPDR S&P Telecom ETF (XTL) is noted for its strong structural growth drivers and a recent valuation of 16.7x P/E. For readers following U.S. technology stocks, here is Pluang's market snapshot as of Sep 28, 2026 16:21 WIB: out of 150 priced Technology-sector US stocks, 23 rose and 106 fell today. Notable movers include NTES (NetEase Inc) at USD 120.06 with a +4.03% change and a typical hold time of 75 days, RBLX (Roblox Corp) at USD 44.58 down -4.01% with a 92-day hold, and INTC (Intel Corp) at USD 118.20 down -3.90% with a 116-day hold time.
A large XRP holder moved 580 million tokens worth about $900 million off exchanges in seven transactions, reducing XRP available for trading. This contributed to $6.76 million in net outflows and a 2.48% drop in XRP's exchange reserves by dollar valu...
Solana transactions are very cheap, costing only 0.000005 SOL per transfer, but each token account requires a minimum balance deposit of 0.00148844 SOL, which is locked while the account is open. This deposit explains why wallet balances appear lower...
Strategy Inc., formerly MicroStrategy, has transformed from a mid-tier software firm into a Bitcoin treasury company with a market cap of $60.94 billion, surpassing First Abu Dhabi Bank's $60.10 billion as of September 2026. This shift was fueled by ...
Syndax Pharmaceuticals is rated a "Strong Buy" due to FDA approval and label expansion for its drugs Revuforj and Niktimvo. Revuforj received FDA approval for relapsed/refractory mNPM1 AML and is being studied for first-line AML treatment. Niktimvo, ...
Venus Protocol introduced a Liquidity Hub on BNB Chain on August 31, 2026, allowing users to deposit USDT, USDC, or U tokens in one place. The Hub automatically distributes funds across three Venus yield sources—Venus Core, Venus Flux, and Institutio...
